About PQ Bypass
PQ Bypass is a company based in Mountain View (United States) founded in 2011 was acquired by Endologix in April 2021. PQ Bypass has raised $71.67 million across 8 funding rounds from investors including Endologix, Informa Connect and Seroba Lifesciences. The company has 1 employees. PQ Bypass offers products and services including Clinically Integrated Networks and Blockchain Integration. PQ Bypass operates in a competitive market with competitors including Avinger, LeMaitre Vascular, Okami Medical, Cagent Vascular and Pathway Medical Technologies, among others.
- Headquarter Mountain View, United States
- Employees 1
- SectorsHealthcare
- Website pqbypass.com
- Acquired by Endologix (Apr 2021)
- Legal Name Pq Bypass, Inc.
Products & Services of PQ Bypass
PQ Bypass offers a comprehensive portfolio of products and services, including Clinically Integrated Networks and Blockchain Integration.
System for coordinating patient care among providers
Secure storage and sharing of patient records
Funding Insights of PQ Bypass
PQ Bypass has successfully raised a total of $71.67M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $71.67M
- Total Rounds 8
- First Round $13.07M
(Dec 2012)
- Investors Count 4
All 8 funding rounds of PQ Bypass with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2018 | $30.9M | Series C | – | – | – |
| Dec 2018 | – | Debt – Conventional | – | – | – |
| Jan 2018 | $222,050 | Series B | – | – | – |
| Apr 2017 | $2.45M | Series B | – | – | – |
| Apr 2016 | $10.04M | Series B | – | – | – |
| Apr 2014 | – | Series B | – | – | |
| Feb 2013 | $15M | Series A | – | Seroba Life Sciences | |
| Dec 2012 | $13.07M | Series A | – | Seroba Life Sciences |
5 investors in total: 5 institutional.
Investors in PQ Bypass
PQ Bypass has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Endologix, Informa Connect and Seroba Lifesciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | abvlp.com | - | |
- | – | fogartyinstitute.org | - | |
Offers live events, digital content, training courses for industry professionals worldwide. | 1993 | informaconnect.com | London, United Kingdom | |
Seroba Lifesciences is focused on life sciences venture capital investments. | – | seroba-lifesciences.com | Dublin, Ireland | |
Minimally invasive treatments for aortic disorders are developed and manufactured. | 1992 | endologix.com | Irvine, United States |
Investor details for PQ Bypass
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PQ Bypass
7 people are tracked at PQ Bypass (6 in leadership, 1 in board & advisors); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Ron Steckel | (Acting) Chief Operating Officer | Leadership |
Steve Van Dick | Consulting Chief Financial Officer | Leadership |
Richard Ferrari | Chairman of the Board and CEO | Leadership |
Marion Larrea | Vice President, Operations | Leadership |
Heather Simonsen | President | Leadership |
Colleen Holthe | Vice President, Clinical Affairs | Leadership |
Stanton Rowe | Director | Board & advisors |
Complete people profiles for PQ Bypass
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PQ Bypass
4 dated milestones of PQ Bypass across 10 years, from founding to its latest funding, stage changes and deals.
- Founded PQ Bypass is founded.
- Funding First funding round of $13.1M.
- Funding Latest funding round, Debt – Conventional,.
- Exit Acquired by Endologix.
Competitors of PQ Bypass
PQ Bypass operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avinger, LeMaitre Vascular, Okami Medical, Cagent Vascular and Pathway Medical Technologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| avinger.com | 2007 | Redwood, United States | $170.85M | 80 | Provider of image-guided catheter-based products for peripheral artery disease | |
| lemaitre.com | 1983 | Burlington, United States | $5.83M | 317 | Devices for peripheral vascular disease treatment are developed and marketed. | |
| okamimedical.com | 2011 | Aliso Viejo, United States | $62.09M | – | Innovative medical devices for peripheral vessel treatment are developed. | |
| cagentvascular.com | 2014 | Wayne, United States | $69.42M | – | Devices for removing vascular blockages are developed. | |
| pathwaymedical.com | 1998 | Kirkland, United States | $101.93M | 158 | Smart devices are provided to clear peripheral arterial blockages. | |
| intactvascular.com | 2011 | Wayne, United States | $123.4M | 64 | Implants for repairing arteries after angioplasty are developed. | |
| venturemedgroup.com | 2012 | Toledo, United States | $51.05M | – | Endovascular devices are developed for PAD and AV fistula treatments. | |
| truvic.com | 2014 | Campbell, United States | $5.89M | – | Smart devices for peripheral vascular thrombus management are developed. | |
| atheromedinc.com | 2006 | Menlo Park, United States | $24.67M | – | Peripheral atherectomy catheter for peripheral arterial disease |
Detailed competitors of PQ Bypass
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pq Bypass
Complete news archive for PQ Bypass
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to PQ Bypass
10 companies that operate in the same segment as PQ Bypass (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PQ Bypass
PQ Bypass was founded in 2011 and raised its 1st funding round 1 year after it was founded.
PQ Bypass is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
PQ Bypass is a funded company, having raised a total of $71.67M across 8 funding rounds to date. The company's 1st funding round was a Series A of $13.07M, raised on Dec 2012.
PQ Bypass has 1 employees.
PQ Bypass was founded in 2011 and is based in Mountain View, United States. Medical devices for a percutaneous femoral artery bypass are provided by the company to address peripheral artery disease. Nearly 500,000 surgical bypasses or lower leg amputations occur worldwide annually for this condition. A CE Mark clinical study has been initiated, with commercialization anticipated in 2017.
PQ Bypass's top competitors include Avinger, Okami Medical and Cagent Vascular.
PQ Bypass offers Clinically Integrated Networks and Blockchain Integration.
PQ Bypass has 5 investors. Key investors include Endologix, Informa Connect, Seroba Lifesciences, Ascent Biomedical Ventures, and Fogarty Institute for Innovation.
PQ Bypass operates through Pq Bypass, Inc..
Yes. PQ Bypass was acquired by Endologix in April 2021.